A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

• Ultra-low PSA Response (<0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes Interactive Poster Session: IP26-07; April 29, 9:30-11:30 a.m. PDT ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

A new form of focal therapy for prostate cancer has made its way to the Natural State, set to be offered by the University of Arkansas for Medical Sciences.Nano ...

Promising results of a study on an at-home saliva test could 'turn the tide on prostate cancer', say experts. Read more.

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers ...

U.K. scientists developed a saliva-based test which better predicts the risk of prostate cancer than current prostate-specific antigen (PSA) blood tests by analyzing DNA to look for genetic variants ...

For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have ...

Assessing prostate-specific antigen levels for 3 months after radical prostatectomy may help minimize overtreatment, ...